©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy
Glaukos

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

Show Description +

Posted: 12/17/2013

Keywords:

iStent

Up Next

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

Glaucoma

The Future of Interventional Glaucoma
The Future of Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

What Does It Mean to Be Interventional?
What Does It Mean to Be Interventional?

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Collaborative Care in Interventional Glaucoma
Collaborative Care in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Case Study: Interventional Glaucoma in the Real World
Case Study: Interventional Glaucoma in the Real World

Achieving Success in Interventional Glaucoma
Achieving Success in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Interventional Glaucoma: Practice Assessments, Insights, and Driving Towards a Consensus-Based Approach to Treating Glaucoma
Interventional Glaucoma: Practice Assessments, Insights, and Driving Towards a Consensus-Based Approach to Treating Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma
The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Practice Assessment Results
Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance
Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Implementing Interventional Glaucoma Treatment Protocols
Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Evolution of the Interventional Glaucoma Mindset
Evolution of the Interventional Glaucoma Mindset

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Re-Evaluating the Conventional Glaucoma Treatment Journey
Re-Evaluating the Conventional Glaucoma Treatment Journey

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Nonadherence or Noncompliance Challenges in Glaucoma Management
Nonadherence or Noncompliance Challenges in Glaucoma Management

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Evaluating Risk of Topical Drops Versus Early Procedural Intervention
Evaluating Risk of Topical Drops Versus Early Procedural Intervention

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Innovative Interventional Glaucoma Technologies
Innovative Interventional Glaucoma Technologies

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Interventional Glaucoma Dinner Discussion
Interventional Glaucoma Dinner Discussion

Billy Pan, MD

Incorporating iDose TR
Incorporating iDose TR

Savak “Sev” Teymoorian, MD, MBA

Patient Education for iDose TR
Patient Education for iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR Patient Selection
iDose TR Patient Selection

Savak “Sev” Teymoorian, MD, MBA

iDose TR: An Interventional Mindset
iDose TR: An Interventional Mindset

Savak “Sev” Teymoorian, MD, MBA

iDose TR: A Patient’s Perspective
iDose TR: A Patient’s Perspective

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Outcomes
iDose TR Postoperative Outcomes

Savak “Sev” Teymoorian, MD, MBA

Making Patients Comfortable With iDose TR
Making Patients Comfortable With iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR: Day of Procedure
iDose TR: Day of Procedure

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Success
iDose TR Postoperative Success

Savak “Sev” Teymoorian, MD, MBA

iDose TR & Interventional Glaucoma
iDose TR & Interventional Glaucoma

Savak “Sev” Teymoorian, MD, MBA

Travoprost Intraocular Implant in Eyes With Prior Selective or Micropulse Laser Trabeculoplasty
Travoprost Intraocular Implant in Eyes With Prior Selective or Micropulse Laser Trabeculoplasty

John P. Berdahl, MD

Travoprost Intraocular Implant: Analysis of Topical Prostaglandin Analog-Associated Adverse Events
Travoprost Intraocular Implant: Analysis of Topical Prostaglandin Analog-Associated Adverse Events

Jason Bacharach, MD

Patient Identification for iDose TR®
Patient Identification for iDose TR®

Savak Teymoorian, MD, MBA; John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; and Lorraine M. Provencher, MD

Live Demonstration: iDose TR® Implantation
Live Demonstration: iDose TR® Implantation

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

iDose TR® Live Procedure Broadcast
iDose TR® Live Procedure Broadcast

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

Expert Panel iDose TR® Q&A Session
Expert Panel iDose TR® Q&A Session

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

Shatter the Status Quo: Introducing iDose® TR
Shatter the Status Quo: Introducing iDose® TR

Ike Ahmed, MD, FRCSC; I. Paul Singh, MD; Mark J. Gallardo, MD; Jason Bacharach, MD; and Sahar Bedrood, MD, PhD

The Standard of Care is Evolving With Interventional Glaucoma
The Standard of Care is Evolving With Interventional Glaucoma

Ike Ahmed, MD, FRCSC

Technology and Procedural Technique for iDose® TR
Technology and Procedural Technique for iDose® TR

I. Paul Singh, MD

Patient Selection and Dialogue for iDose® TR
Patient Selection and Dialogue for iDose® TR

Mark J. Gallardo, MD

Clinical Data From iDose® TR
Clinical Data From iDose® TR

Jason Bacharach, MD

Advancing Interventional Glaucoma
Advancing Interventional Glaucoma

Sahar Bedrood, MD, PhD

A Glaucoma Treatment Revolution With iStent infinite®
A Glaucoma Treatment Revolution With iStent infinite®

Deborah Ristvedt, DO; and Manjool Shah, MD

Elegantly Precise Microsurgery With iStent infinite®
Elegantly Precise Microsurgery With iStent infinite®

Deborah Ristvedt, DO; and Manjool Shah, MD

Live Surgery Demonstration of iStent infinite®
Live Surgery Demonstration of iStent infinite®

Blake K. Williamson, MD, MPH, MS; Manjool Shah, MD; and Deborah Ristvedt, DO

Defining Success With Interventional Glaucoma
Defining Success With Interventional Glaucoma

Blake K. Williamson, MD, MPH, MS; Manjool Shah, MD; and Deborah Ristvedt, DO

Sustained 7-Year Glaucoma Control After Second-Generation Trabecular Microbypass With or Without Cataract Surgery Featuring the iStent <i>inject</i>
Sustained 7-Year Glaucoma Control After Second-Generation Trabecular Microbypass With or Without Cataract Surgery Featuring the iStent inject

Fritz Hengerer, MD

Prospective Study of Standalone Multiple Trabecular Microbypass Stents for Uncontrolled Glaucoma
Prospective Study of Standalone Multiple Trabecular Microbypass Stents for Uncontrolled Glaucoma

Steven R. Sarkisian Jr, MD

Endothelial Safety Profile of Minimally Invasive Glaucoma Surgery Stents
Endothelial Safety Profile of Minimally Invasive Glaucoma Surgery Stents

Thomas Samuelson, MD

iStent Infinite® Live Surgery Broadcast
iStent Infinite® Live Surgery Broadcast

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Interventional Glaucoma
Interventional Glaucoma

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

The iStent Infinite®
The iStent Infinite®

Sahar Bedrood, MD, PhD; and I. Paul Singh, MD

iStent Infinite® Surgery
iStent Infinite® Surgery

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Procedure Using iAccess and iStent <em>inject</em> W
Procedure Using iAccess and iStent inject W

Mark J. Gallardo, MD

Defining a Treatment Algorithm
Defining a Treatment Algorithm

Inder Paul Singh, MD; and Sahar Bedrood, MD, PhD

Most Studied MIGS Device: Pivotal and Real-World Data
Most Studied MIGS Device: Pivotal and Real-World Data

Jacob Brubaker, MD

Glaukos History, Legacy, and Expanding Portfolio
Glaukos History, Legacy, and Expanding Portfolio

Mark J. Gallardo, MD

iAccess Trabecular Trephine
iAccess Trabecular Trephine

Blake Williamson, MD, MPH, MS

Stenting and Microgoniotomy
Stenting and Microgoniotomy

Inder Paul Singh, MD

iAccess Microgoniotomy
iAccess Microgoniotomy

Inder Paul Singh, MD

Pivotal Trail Shows Value of iStent <em>inject</em> – Stratified Results Across Disease Levels
Pivotal Trail Shows Value of iStent inject – Stratified Results Across Disease Levels

I. Paul Singh, MD

Maximizing Quality of Life with the iStent <em>inject</em>
Maximizing Quality of Life with the iStent inject

I. Paul Singh, MD

MIGS Evolution & Treatment Algorithm: Where to Start?
MIGS Evolution & Treatment Algorithm: Where to Start?

Thomas Samuelson, MD

iStent Technologies: Real-World Data
iStent Technologies: Real-World Data

Leon W. Herndon, MD

Integrating a Good Fit Into Your Practice
Integrating a Good Fit Into Your Practice

Deborah Ristvedt, DO

Treating the Spectrum of Glaucoma with Current & Future Technologies
Treating the Spectrum of Glaucoma with Current & Future Technologies

Mark J. Gallardo, MD

My Mild to Moderate Glaucoma Treatment Algorithm
My Mild to Moderate Glaucoma Treatment Algorithm

Christophe Baudouin, MD, PhD

Aqueous Angiography: The Importance of the Pump
Aqueous Angiography: The Importance of the Pump

Alex Huang, MD, PhD

iStent inject W: Real World Data
iStent inject W: Real World Data

Fritz Hengerer, MD

Implementing iStent inject W in Your Practice
Implementing iStent inject W in Your Practice

Inder Paul Singh, MD

Achieving Success with the iStent <i>inject</i>
Achieving Success with the iStent inject

Inder Paul Singh, MD

iStent <i>inject</i> in My Practice
iStent inject in My Practice

Sahar Bedrood, MD, PhD

Outflow Imaging and Trabecular Bypass
Outflow Imaging and Trabecular Bypass

Alex Huang, MD

iStent <i>inject</i>: Time to Transition
iStent inject: Time to Transition

Neda Shamie, MD

iStent <i>inject</i>: The Glaucoma Surgeon's Perspective
iStent inject: The Glaucoma Surgeon's Perspective

Sahar Bedrood, MD, PhD

An Overview of the iStent <i>inject</i>
An Overview of the iStent inject

Blake K. Williamson, MD, MPH, MS

Take a Team Approach to the iStent <em>inject</em>
Take a Team Approach to the iStent inject

Neda Shamie, MD

What Sparked My Interest to Incorporate MIGS
What Sparked My Interest to Incorporate MIGS

Neda Shamie, MD

A Safe Surgical Option for Cataract Patients with Glaucoma
A Safe Surgical Option for Cataract Patients with Glaucoma

Florian Kretz, MD, FEBO

Why I Choose the <em>iStent</em> inject?
Why I Choose the iStent inject?

John A. Hovanesian MD

A MIGS Device for the Premium Practice: iStent <i>inject</i>®
A MIGS Device for the Premium Practice: iStent inject®

Blake K. Williamson, MD, MPH, MS

iStent <em>inject</em><sup>®</sup> in the Refractive Cataract Practice
iStent inject® in the Refractive Cataract Practice

Robert J. Cionni, MD

Increasing Your Firepower with iStent <em>inject</em><sup>®</sup>
Increasing Your Firepower with iStent inject®

Arsham Sheybani, MD

Eliminating MIGS Barriers with iStent <em>inject</em><sup>®</sup>
Eliminating MIGS Barriers with iStent inject®

John P. Berdahl, MD

Exceptional Outcomes with the iStent <em>inject</em><sup>®</sup>
Exceptional Outcomes with the iStent inject®

Thomas W. Samuelson, MD

iStent <em>inject</em><sup>®</sup> - The Next Generation of Microinvasive Glaucoma Surgery
iStent inject® - The Next Generation of Microinvasive Glaucoma Surgery

Iqbal Ike K. Ahmed, MD, FRCSC

Visual Outcomes With the iStent
Visual Outcomes With the iStent

Arsham Sheybani, MD

When to Use MIGS: The Refractive Cataract Specialist Perspective
When to Use MIGS: The Refractive Cataract Specialist Perspective

Kerry Solomon, MD

The Learning Curve
The Learning Curve

Elizabeth Yeu, MD

When to Use MIGS: The Glaucoma Specialist Perspective
When to Use MIGS: The Glaucoma Specialist Perspective

Mark Gallardo, MD

Surgical Outcomes of the iStent
Surgical Outcomes of the iStent

Tal Raviv, MD

Offering Patients a Premium Experience
Offering Patients a Premium Experience

Nathan Radcliffe, MD

MIGS and Your Practice
MIGS and Your Practice

Arsham Sheybani, MD

Safety of the iStent
Safety of the iStent

Arsham Sheybani, MD

Working With a Referral Base
Working With a Referral Base

Arsham Sheybani, MD

iStent Learning Curve
iStent Learning Curve

Tal Raviv, MD

Addressing Glaucoma at the Time of Cataract Surgery
Addressing Glaucoma at the Time of Cataract Surgery

Nathan Radcliffe, MD

The iStent Procedure
The iStent Procedure

Arsham Sheybani, MD

What To Expect When Adopting the iStent
What To Expect When Adopting the iStent

Nathan Radcliffe, MD

MIGS Technology and the Future
MIGS Technology and the Future

Tal Raviv, MD

Safety of the iStent
Safety of the iStent

Tal Raviv, MD

Making the MIGS Algorithm Work
Making the MIGS Algorithm Work

Ike Ahmed, MD

Adding MIGS to Your Armamentarium
Adding MIGS to Your Armamentarium

Elizabeth Yeu, MD

The iStent Journey
The iStent Journey

Kerry Solomon, MD

Surgical Outcomes
Surgical Outcomes

Elizabeth Yeu, MD

Techniques for Implanting the iStent
Techniques for Implanting the iStent

Elizabeth Yeu, MD

Disruptive Technology That Won't Disrupt Your Practice
Disruptive Technology That Won't Disrupt Your Practice

Cathleen McCabe, MD

MIGS Economics 101
MIGS Economics 101

Matt Jensen

Cases That Catch Your Eye
Cases That Catch Your Eye

Steven Sarkisian, MD

Raising the Outcomes Bar
Raising the Outcomes Bar

Robert Cionni, MD

The iStent Premium Package
The iStent Premium Package

Jeffrey Whitman, MD

Efficacy With the iStent
Efficacy With the iStent

I. Paul Singh, MD

Increased Surgical Efficiency With the iStent
Increased Surgical Efficiency With the iStent

David Goldman, MD

Pearls for Using the iStent in Cataract Surgery
Pearls for Using the iStent in Cataract Surgery

Mitchell Shultz, MD

The Evolution of MIGS and the iStent Journey
The Evolution of MIGS and the iStent Journey

Richard Lindstrom, MD

Refining iStent Microsurgery: Making a Case for Safer Glaucoma Intervention
Refining iStent Microsurgery: Making a Case for Safer Glaucoma Intervention

Thomas Samuelson, MD

Why I Adopted iStent as a Refractive Cataract & Corneal Surgeon
Why I Adopted iStent as a Refractive Cataract & Corneal Surgeon

Edward Holland, MD

Making It Work for You: Optimizing iStent in Your Practice
Making It Work for You: Optimizing iStent in Your Practice

John Berdahl, MD

What's Next: The Future of Titratable Therapy
What's Next: The Future of Titratable Therapy

Ike Ahmed, MD

Why iStent
Why iStent

David Goldman MD, Thomas Samuelson, MD

Surgical Pearls
Surgical Pearls

David Goldman MD, Thomas Samuelson, MD

Data Review
Data Review

David Goldman MD, Thomas Samuelson, MD

Practice Success
Practice Success

David Goldman MD, Thomas Samuelson, MD

MIGS: Glaukos iStent User Group: Surgical Approach to MIGS
MIGS: Glaukos iStent User Group: Surgical Approach to MIGS

Ike K. Ahmed MD, L. Jay Katz MD, Richard A. Lewis MD, Thomas W. Samuelson MD

Surgical Approach to MIGS: Part 6
Surgical Approach to MIGS: Part 6

Surgical Approach to MIGS: Part 5
Surgical Approach to MIGS: Part 5

Surgical Approach to MIGS: Part 4
Surgical Approach to MIGS: Part 4

Surgical Approach to MIGS: Part 3
Surgical Approach to MIGS: Part 3

Surgical Approach to MIGS: Part 2
Surgical Approach to MIGS: Part 2

Surgical Approach to MIGS: Part 1
Surgical Approach to MIGS: Part 1

MIGS: Glaukos iStent User Group - A True Team Effort, Part 5
MIGS: Glaukos iStent User Group - A True Team Effort, Part 5

MIGS: Glaukos iStent User Group - A True Team Effort, Part 4
MIGS: Glaukos iStent User Group - A True Team Effort, Part 4

MIGS: Glaukos iStent User Group - A True Team Effort, Part 3
MIGS: Glaukos iStent User Group - A True Team Effort, Part 3

MIGS: Glaukos iStent User Group - A True Team Effort, Part 2
MIGS: Glaukos iStent User Group - A True Team Effort, Part 2

MIGS: Glaukos iStent User Group - A True Team Effort, Part 1
MIGS: Glaukos iStent User Group - A True Team Effort, Part 1

MIGS: Glaukos iStent User Group: Case Studies - Part 7
MIGS: Glaukos iStent User Group: Case Studies - Part 7

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 6
MIGS: Glaukos iStent User Group: Case Studies - Part 6

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 5
MIGS: Glaukos iStent User Group: Case Studies - Part 5

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 4
MIGS: Glaukos iStent User Group: Case Studies - Part 4

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 3
MIGS: Glaukos iStent User Group: Case Studies - Part 3

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 2
MIGS: Glaukos iStent User Group: Case Studies - Part 2

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 1
MIGS: Glaukos iStent User Group: Case Studies - Part 1

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 6
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 6

Steven D. Vold, MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 5
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 5

Steven D. Vold, MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 4
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 4

Robert Cionni MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 3
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 3

Robert Cionni MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 2
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 2

Richard A. Lewis MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 1
MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 1

Richard A. Lewis MD

Glaukos Symposia Part 13.
Glaukos Symposia Part 13.

Glaukos Symposia Part 12
Glaukos Symposia Part 12

Glaukos Symposia Part 11
Glaukos Symposia Part 11

Glaukos Symposia Part 10
Glaukos Symposia Part 10

Glaukos Symposia Part 9
Glaukos Symposia Part 9

Glaukos Symposia Part 8
Glaukos Symposia Part 8

Glaukos Symposia Part 7
Glaukos Symposia Part 7

Glaukos Symposia Part 6
Glaukos Symposia Part 6

Glaukos Symposia Part 5
Glaukos Symposia Part 5

Glaukos Symposia Part 4
Glaukos Symposia Part 4

Glaukos Symposia Part 3
Glaukos Symposia Part 3

Glaukos Symposia Part 2
Glaukos Symposia Part 2

Glaukos Symposia Part 1
Glaukos Symposia Part 1

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 5
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 5

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 2
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 2

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 1
MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 1

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

Corneal Health

Drafting Your Keratoconus Quarterback
Drafting Your Keratoconus Quarterback

Brandon D. Ayres, MD; and Priya M. Mathews, MD, MPH

Optimizing Your Keratoconus Management Playbook
Optimizing Your Keratoconus Management Playbook

Brandon D. Ayres, MD; and Eva Kim, MD

Establish a Game Plan for Treating Bilateral Keratoconus
Establish a Game Plan for Treating Bilateral Keratoconus

Brandon D. Ayres, MD; and John Berdahl, MD

Use Your Dream Team to Execute Your Keratoconus Strategy
Use Your Dream Team to Execute Your Keratoconus Strategy

Brandon D. Ayres, MD; Susan DeGroot, MBA; and Vivian Cole, BA

link-arrow   Back to All Videos

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

Posted: 12/17/2013

Keywords:

iStent

Resources

New Surgical Technologies to Expand Your Treatment Algorithm

View Resource

iStent: A Powerful, Predictable, and Proven Technology

View Resource

Maximize Efficacy Minimize Concerns

Read Supplement

Why I Choose the iStent Inject

Read Supplement

Matching Glaucoma Patient Needs With the Right Procedure

Read Supplement

Choosing iStent for the Refractive Cataract Practice

Read Supplement

Goals of Treating Glaucoma During Cataract Surgery

Read Supplement

About Glaukos

Contact Us: glaukos.com/contact-us

Schedule a Demo | Request a Brochure | Get a Quote | Have Someone Contact Me